RGNX
REGENXBIO Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.92
−3.04%2
Insider buys (3m)
3
Insider sells (3m)
$231.1K
Net value (3m)
+32.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Malzahn Craig · officer: Chief Technology Officer | F-InKind | 234 | $9.32 |
| Sep 3, 2026 | Chan Mitchell · officer: Chief Financial Officer | F-InKind | 4,902 | $9.32 |
| Aug 27, 2026 | Ciongoli Gregory Austin · director | A-Award | 69,609 | $8.91 |
| Aug 27, 2026 | Ciongoli Gregory Austin · director | Purchase | 53,407 | $9.36 |
| Aug 27, 2026 | Ciongoli Gregory Austin · director | Purchase | 49,196 | $9.14 |
| Aug 27, 2026 | Ciongoli Gregory Austin · director | A-Award | 15,432 | $0.00 |
| Aug 4, 2026 | PAKOLA STEVE · officer: Chief Medical Officer | F-InKind | 7,468 | $9.69 |
| Aug 4, 2026 | Christmas Patrick J. · officer: Chief Strategy & Legal Officer | F-InKind | 4,699 | $9.69 |
| Jul 6, 2026 | Simpson Curran · director, officer: Chief Executive Officer | F-InKind | 6,818 | $13 |
| Jul 6, 2026 | PAKOLA STEVE · officer: Chief Medical Officer | M-Exempt | 2,161 | $7.86 |
| Jul 6, 2026 | Simpson Curran · director, officer: Chief Executive Officer | A-Award | 951 | $7.00 |
| Jul 6, 2026 | Simpson Curran · director, officer: Chief Executive Officer | A-Award | 1,453 | $10 |
| Jul 6, 2026 | PAKOLA STEVE · officer: Chief Medical Officer | Sale | 2,161 | $14 |
| Jul 1, 2026 | PAKOLA STEVE · officer: Chief Medical Officer | Sale | 19,608 | $11 |
| Jul 1, 2026 | PAKOLA STEVE · officer: Chief Medical Officer | M-Exempt | 36,725 | $7.86 |
| Jul 1, 2026 | PAKOLA STEVE · officer: Chief Medical Officer | Sale | 36,725 | $13 |
| Jun 2, 2026 | MIGAUSKY GEORGE V · director | A-Award | 9,807 | $0.00 |
| Jun 2, 2026 | Zachary Jennifer · director | A-Award | 9,807 | $0.00 |
| Jun 2, 2026 | KARABELAS ARGERIS N · director | A-Award | 9,807 | $0.00 |
| Jun 2, 2026 | MIGAUSKY GEORGE V · director | A-Award | 46,600 | $7.01 |
| Jun 2, 2026 | STUMP DAVID C · director | A-Award | 46,600 | $7.01 |
| Jun 2, 2026 | Bennett Jean · director | A-Award | 9,807 | $0.00 |
| Jun 2, 2026 | KARABELAS ARGERIS N · director | A-Award | 46,600 | $7.01 |
| Jun 2, 2026 | STUMP DAVID C · director | A-Award | 9,807 | $0.00 |
| Jun 2, 2026 | Zachary Jennifer · director | A-Award | 46,600 | $7.01 |
| Jun 2, 2026 | Tasse Daniel · director | A-Award | 46,600 | $7.01 |
| Jun 2, 2026 | Fox Allan M. · director | A-Award | 46,600 | $7.01 |
| Jun 2, 2026 | Tasse Daniel · director | A-Award | 9,807 | $0.00 |
| Jun 2, 2026 | Mills Kenneth T. · director | A-Award | 46,600 | $7.01 |
| Jun 2, 2026 | Glucksmann Alexandra · director | A-Award | 46,600 | $7.01 |
Institutional positioning
13F filings over the trailing two quarters
New 59Increased 121Reduced 119Sold out 34
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 6,397,440 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 5,782,808 | May 13, 2026 |
| REDMILE GROUP, LLC | Unchanged | 4,368,804 | May 15, 2026 |
| Redmile Group, LLC | Unchanged | 4,368,804 | Aug 14, 2026 |
| JPMORGAN CHASE & CO | Reduced | 3,483,800 | May 13, 2026 |
| STATE STREET CORP | Increased | 2,971,173 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 2,731,485 | May 15, 2026 |
| JPMORGAN CHASE & CO | Reduced | 2,214,169 | Aug 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2,107,557 | Aug 13, 2026 |
| MORGAN STANLEY | Reduced | 2,066,157 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,007,146 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 1,953,237 | Aug 13, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 1,839,463 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 1,785,437 | Mar 25, 2026 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | Increased | 1,500,000 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026